Literature DB >> 9252538

Effect of hyperoxia on substance P expression and airway reactivity in the developing lung.

F H Agani1, N T Kuo, C H Chang, I A Dreshaj, C F Farver, J E Krause, P Ernsberger, M A Haxhiu, R J Martin.   

Abstract

This study was undertaken to characterize changes in the tachykinin system induced by hyperoxic exposure and the potential effects on airway contractile responses. We exposed 7-day-old rat pups to either room air or hyperoxia (> 95% O2) for 7 days to assess pulmonary beta-preprotachykinin (beta-PPT) gene expression, substance P (SP) levels, and airway contractile responses to cholinergic stimulation before and after neurokinin-1 (NK1) receptor blockade. Lung beta-PPT mRNA expression, lung and tracheal SP levels, and contractile responses to exogenous acetylcholine and electrical field stimulation were measured in vitro in normoxia- and hyperoxia-exposed tracheal cylinders. Hyperoxia caused a 1.1- to 2.6-fold increase in steady-state lung beta-PPT mRNA and a 50 and 32% increase in SP levels of lung and trachea, respectively. In response to cholinergic stimulation, maximal contractile force (Emax) of hyperoxia exposed tracheal muscle was significantly higher than for normoxic controls. Addition of the SP (NK1) receptor blocker CP-99994 (10 microM) decreased sensitivity to electrical field stimulation in both hyperoxic and normoxic trachea without a significant decline in Emax. These data provide evidence for both increased SP production and enhanced maximal contractile responses of hyperoxia-exposed neonatal trachea to cholinergic stimulation. The tachykinin peptide SP does not, however, appear to play a major role in the enhanced airway reactivity associated with hyperoxic lung injury during early postnatal life.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252538     DOI: 10.1152/ajplung.1997.273.1.L40

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  Neurokinin-neurotrophin interactions in airway smooth muscle.

Authors:  Lucas W Meuchel; Alecia Stewart; Dan F Smelter; Amard J Abcejo; Michael A Thompson; Syed I A Zaidi; Richard J Martin; Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-22       Impact factor: 5.464

2.  Early exposure to hyperoxia or hypoxia adversely impacts cardiopulmonary development.

Authors:  Manimaran Ramani; Wayne E Bradley; Louis J Dell'Italia; Namasivayam Ambalavanan
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

3.  Perinatal factors in neonatal and pediatric lung diseases.

Authors:  Rodney D Britt; Arij Faksh; Elizabeth Vogel; Richard J Martin; Christina M Pabelick; Y S Prakash
Journal:  Expert Rev Respir Med       Date:  2013-10-03       Impact factor: 3.772

4.  Oxygen dose responsiveness of human fetal airway smooth muscle cells.

Authors:  William R Hartman; Dan F Smelter; Venkatachalem Sathish; Michael Karass; Sunchin Kim; Bharathi Aravamudan; Michael A Thompson; Yassine Amrani; Hitesh C Pandya; Richard J Martin; Y S Prakash; Christina M Pabelick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-08-24       Impact factor: 5.464

5.  Inhaled corticosteroids for abnormal pulmonary function in children with a history of chronic lung disease of infancy: study protocol [ISRCTN55153521].

Authors:  Saad Alotaibi; David Johnson; Mark Montegomery; Reginald Sauve; Sheldon Spier
Journal:  BMC Pulm Med       Date:  2005-04-12       Impact factor: 3.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.